Granulocyte colony stimulating factor alters the phenotype of neuroblastoma cells: implications for disease-free survival of high-risk patients

Journal of Pediatric Surgery

Volumn 43, Issue 5, 2008, Pages 837-842

  Gay, Andre N ^a   Chang, Shirong ^a   Rutland, Lindsey ^a   Yu, Ling ^a   Byeseda, Sarah ^a   Naik Mathuria, Bindi ^a   Cass, Darrell L ^a   Russell, Heidi ^b   Olutoye, Oluyinka O ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b TEXAS CHILDREN S HOSPITAL   (United States)

Author keywords

Childhood tumor; Cytokine; GCSF; GCSF receptor; Neuroblastoma; Recurrence

Indexed keywords

GRANULOCYTE COLONY STIMULATING FACTOR; GRANULOCYTE COLONY STIMULATING FACTOR RECEPTOR;

ARTICLE; CANCER INVASION; CELL PROLIFERATION; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE FREE SURVIVAL; DNA SYNTHESIS; HIGH RISK PATIENT; HUMAN; HUMAN CELL; NEUROBLASTOMA; NEUROBLASTOMA CELL; PHENOTYPE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION;

BASE PAIRING; CELL LINE, TUMOR; CELL PROLIFERATION; CHILD; CHILD, PRESCHOOL; DISEASE-FREE SURVIVAL; DNA, NEOPLASM; GRANULOCYTE COLONY-STIMULATING FACTOR; HUMANS; INFANT; NEOPLASM INVASIVENESS; NEUROBLASTOMA; PHENOTYPE; RECEPTORS, GRANULOCYTE COLONY-STIMULATING FACTOR;

EID: 43249099814     PISSN: 00223468     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpedsurg.2007.12.024     Document Type: Article

References (17)

1. Matthay K.K., Villablanca J.G., Seeger R.C., et al. Treatment of high-risk neuroblastoma with intensive chemotherapy, radiotherapy, autologous bone marrow transplantation, and 13-cis-retinoic acid. Children's Cancer Group. N Engl J Med 341 (1999) 1165-1173
2. Cheung N.V., and Heller G. Chemotherapy dose intensity correlates strongly with response, median survival, and median progression-free survival in metastatic neuroblastoma. J Clin Oncol 9 (1991) 1050-1058
3. Grupp S.A., Stern J.W., Bunin N., et al. Tandem high-dose therapy in rapid sequence for children with high-risk neuroblastoma. J Clin Oncol 18 (2000) 2567-2575
4. Michon J.M., Hartmann O., Bouffet E., et al. An open-label, multicentre, randomised phase 2 study of recombinant human granulocyte colony-stimulating factor (filgrastim) as an adjunct to combination chemotherapy in paediatric patients with metastatic neuroblastoma. Eur J Cancer 34 (1998) 1063-1069
5. Kanold J., Rapatel C., Berger M., et al. Use of G-CSF alone to mobilize peripheral blood stem cells for collection from children. Br J Haematol 88 (1994) 633-635
6. Schroeder H., Kamperis K., Grunnet N., et al. Prediction of target CD34 positive cells following leukopheresis in children with neuroblastoma. Pediatr Blood Cancer 46 (2006) 786-792
7. Kletzel M., Katzenstein H.M., Haut P.R., et al. Treatment of high-risk neuroblastoma with triple-tandem high-dose therapy and stem-cell rescue: results of the Chicago Pilot II Study. J Clin Oncol 20 (2002) 2284-2292
8. George R.E., Li S., Medeiros-Nancarrow C., et al. High-risk neuroblastoma treated with tandem autologous peripheral-blood stem cell-supported transplantation: long-term survival update. J Clin Oncol 24 (2006) 2891-2896
9. Gutschalk C.M., Herold-Mende C.C., Fusenig N.E., et al. Granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor promote malignant growth of cells from head and neck squamous cell carcinomas in vivo. Cancer Res 66 (2006) 8026-8036
10. Mroczko B., Szmitkowski M., and Niklinski J. Granulocyte-colony stimulating factor and macrophage-colony stimulating factor in patients with non-small-cell lung cancer. Clin Chem Lab Med 39 (2001) 374-379
11. Nakata H., Uemura Y., Kobayashi M., et al. Cyclooxygenase-2 inhibitor NS-398 suppresses cell growth and constitutive production of granulocyte-colony stimulating factor and granulocyte macrophage-colony stimulating factor in lung cancer cells. Cancer Sci 94 (2003) 173-180
12. Chakraborty A., White S.M., and Lerner S.P. Granulocyte colony-stimulating factor receptor signals for beta1-integrin expression and adhesion in bladder cancer. Urology 63 (2004) 177-183
13. Pirtskhalaishvili G., and Nelson J.B. Endothelium-derived factors as paracrine mediators of prostate cancer progression. Prostate 44 (2000) 77-87
14. Stute N., Santana V.M., Rodman J.H., et al. Pharmacokinetics of subcutaneous recombinant human granulocyte colony-stimulating factor in children. Blood 79 (1992) 2849-2854
15. Schneider A., Kruger C., Steigleder T., et al. The hematopoietic factor G-CSF is a neuronal ligand that counteracts programmed cell death and drives neurogenesis. J Clin Invest 115 (2005) 2083-2098
16. Nitta T., Sato K., Allegretta M., et al. Expression of granulocyte colony stimulating factor and granulocyte-macrophage colony stimulating factor genes in human astrocytoma cell lines and in glioma specimens. Brain Res 571 (1992) 19-25
17. Morel M., Beaujean F., Le Forestier C., et al. Effect of human granulocyte colony stimulating factor on neuroblastoma cell growth. Biomed Pharmacother 47 (1993) 29-32